| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6054965 | Oral Oncology | 2014 | 8 Pages |
Abstract
These data suggest the possibility of combining targeted therapeutic such as linifanib with veliparib to augment the inhibition of cell growth and apoptosis via synthetic lethality in HNSCC cells. Thus, it may provide a novel therapeutic strategy and improve efficacy and outcome in HNSCC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Heng-Wei Hsu, Rosalia de Necochea-Campion, Vonetta Williams, Penelope J. Duerksen-Hughes, Alfred A. Jr., Robert L. Ferris, Chien-Shing Chen, Saied Mirshahidi,